Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Comment by MrMonkon Mar 04, 2013 8:18pm
197 Views
Post# 21077051

RE: RE: RE: AURIZON ENTERS INTO DEFINITIVE AGREEME

RE: RE: RE: AURIZON ENTERS INTO DEFINITIVE AGREEME

Will be interesting to see how all this plays out.  I suspect this new development will further distract (delay) ARZ from a decision on Marban.  However, the clock is ticking and they'll eventually need to **** or get off the pot.  It has been said many times that NOX is in a very good position regardless of what ARZ decides.

If ARZ/Hecla doesn't continue with Marban, I suspect that NOX will not be going it alone.  My educated guess is that other potential partners are lined up at the door.  Junior, intermediate and large miners need to replace diminishing production and deposits like Marban are few and far between.  Hold on to your hats - we have quite a ride ahead of us if we can continue to be patient and keep our eyes squarely focused on the prize.

Does anyone know anything about Hecla?  I know they're well-managed.  Anything else that may give us clues as to their plans for Marban?

 

- MM

<< Previous
Bullboard Posts
Next >>